Sesen Bio to Host Conference Call to Review First Quarter 2021 Financial Results and Provide Business Update on Monday, May 10, 2021

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that the Company’s management team will host a conference call to review operating results for the first quarter ended March 31, 2021 and provide a business update. The conference call is scheduled for Monday, May 10, 2021 at 8:00 am ET. To participate in the conference call, please dial (844) 831-30